Cargando…
Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers
DNA methylation alterations have already been linked to cancer, and their usefulness for therapy and diagnosis has encouraged research into the human epigenome. Several biomarker studies have focused on identifying cancer types individually, yet common cancer and multicancer markers are still undere...
Autores principales: | Ibrahim, Joe, Op de Beeck, Ken, Fransen, Erik, Peeters, Marc, Van Camp, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208075/ https://www.ncbi.nlm.nih.gov/pubmed/34978357 http://dx.doi.org/10.1002/1878-0261.13176 |
Ejemplares similares
-
The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types
por: Ibrahim, Joe, et al.
Publicado: (2019) -
Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer
por: Ibrahim, Joe, et al.
Publicado: (2019) -
Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer
por: Croes, Lieselot, et al.
Publicado: (2018) -
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
por: Janssens, Katleen, et al.
Publicado: (2023) -
DFNA5 promoter methylation a marker for breast tumorigenesis
por: Croes, Lieselot, et al.
Publicado: (2017)